ArticlebioRxiv : the preprint server for biology2025

Targeting Semaphorin 7a signaling in preclinical models of estrogen receptor-positive breast cancer.

Rachel N Steinmetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.